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Abstract
Background: Cardiopulmonary exercise testing (CPET) identifies high-risk patients before major surgery. In addition to
using oxygen uptake and ventilatory efficiency to assess functional capacity, CPET can be used to identify underlying
myocardial dysfunction through the assessment of the oxygen uptake to heart rate response (oxygen pulse response).
We examined the relationship of oxygen pulse response, in combination with other CPET variables and known cardiac
risk factors, with mortality after colorectal cancer surgery.
Methods: This work focused on a retrospective cohort study of patients who had CPET and underwent colorectal cancer
surgery. The primary outcome was a composite of in-hospital and 30-day mortality. Ventilatory inefficiency (VE/VCO2>34)
and exercise-induced myocardial dysfunction (abnormal oxygen pulse response) were investigated for an association
with mortality using bivariable analysis and multivariable Cox regression.
Results: A total of 1214 patients who underwent colorectal cancer surgery were included, and the primary outcome
occurred in 26 patients (2.1%). Multivariable Cox regression showed abnormal oxygen pulse response was independently
associated with the primary outcome (odds ratio [OR]¼2.75; 95% confidence interval [CI], 1.17e6.47). Bivariable analysis
showed that VE/VCO2 >34 was associated with the primary outcome (OR¼3.43; 95% CI, 1.47e8.01). Combining VE/VCO2 >34
and abnormal oxygen pulse response conferred an increased risk for the primary outcome (OR¼4.47; 95% CI, 1.62e12.34),
compared with VE/VCO2 >34 and normal oxygen pulse response.
Conclusion: Ventilatory inefficiency and an abnormal oxygen pulse response were independently associated with short-
(30-day) and long-term (2-yr) mortality. Oxygen pulse response may provide additional information when considering
perioperative risk stratification.
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Editor’s key points
 Cardiopulmonary exercise testing can be used to
generate indices of cardiac dysfunction.
 Peak oxygen pulse and oxygen pulse response have been
associated with increased mortality in heart failure.
 This study found that an abnormal oxygen pulse
response was associated with mortality after colorectal
surgery.
 Future studies are warranted to define thresholds in
colorectal and other types of surgery.
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Clinical Investigation
Major surgery is associated with a high incidence of post-
operative complications and places a significant burden on
healthcare resources.1 Approximately 30 000 patients were
diagnosed with bowel cancer in the UK in 2015e16, with
almost 20 000 of these undergoing major colorectal resections.
Of those proceeding to major resection, 1.9% of patients died
within 90 days after planned surgery.2 In order to reduce
mortality rates in elective surgery, it is necessary to identify
patients at increased risk so interventions whichmay improve
outcome can be focused on this group.
Standard preoperative assessment alone has limitations
when trying to identify the higher risk patient. Reduced aer-
obic fitness, or impaired functional capacity, is predictive of
worse outcomes after major elective surgery.3e5 We know that
physician assessment of functional capacity is unreliable, and
although self-reporting by patients may have some utility,6
objective measurement of aerobic fitness using cardiopulmo-
nary exercise testing (CPET) provides the most accurate in-
formation. Reduced functional capacity as measured by CPET
has repeatedly been shown to be associated with a poorer
outcome after operation.3e5
Using CPET, reduced functional capacity can be determined
by measurement of peak oxygen consumption, oxygen con-
sumption at anaerobic threshold (AT) or
ventilationeperfusion (V/Q) mismatching through CPET.7 Pa-
tients with V/Q mismatch require a higher minute volume to
excrete the same amount of carbon dioxide (CO2) produced
compared to those that do not. It is measured as the ratio of
minute ventilation to CO2 production (VE/VCO2) and termed the
ventilatory equivalent for CO2. Increased VE/VCO2 has multiple
aetiologies, including heart failure, obstructive airway disease,
pulmonary hypertension, pulmonary embolism, and decon-
ditioning. All aetiologies can cause increasing values, which
indicate higher degrees of V/Q mismatch and relate to a
reduction in functional capacity. A range of values of VE/VCO2
measured at AT from >34 to >39 has shown to be predictive of
mortality in surgical3,8 and heart failure populations.3,9e11
In addition to measures of functional capacity, CPET can
generate additional variables associated with underlying
myocardial dysfunction or ischaemic heart disease.12 Oxygen
uptake divided by heart rate is known as oxygen pulse, and is a
surrogate for stroke volume by the application of the Fick
principle.13 Plotting oxygen pulse by time allows the inter-
pretation of oxygen pulse throughout the duration of the test,
and at our trust, is termed oxygen pulse response. Myocardial
dysfunction is characterised by a patient’s reduced ability to
increase stroke volume during incremental exercise and pre-
cedes the development of ST segment changes and angina.12
Oxygen pulse response has been shown to be more specific
for the diagnosis of ischaemic heart disease when compared
with standard treadmill ECG testing.12 This may confer an
advantage over static measurements of cardiac function
which may not detect early or subtle exercise-induced
myocardial dysfunction (EIMD), such as ECG and
echocardiography.12
The aim of this study was to evaluate the oxygen pulse
response as an adjunct to other CPET parameters for risk
prediction of mortality after major elective colorectal surgery.
Methods
We conducted a retrospective analysis of prospectively ac-
quired data that aimed to investigate CPET parameters and
adverse postoperative outcomes. York Teaching Hospital
Foundation Trust sponsored the study, which was approved
by the UK Health Research Authority (IRAS 228489).
Data extracts were anonymised and analysed for the period
June 1, 2004 to December 31, 2016 for patients older than 55 yr,
or younger if any known cardiorespiratory risk factors were
present, who were referred for a preoperative evaluation,
including CPET, and subsequently underwent surgery for
colorectal cancer. A description of the York CPET protocol has
been described elsewhere.3 Patients who did not undergo
colorectal cancer surgery or did not have an oxygen pulse
response recorded were excluded.
All preoperative data were recorded prospectively on a
secure trust database and included patient demographics (age,
sex, height, weight, and BMI), presence of metastatic disease,
co-morbidities (ischaemic heart disease, cerebrovascular dis-
ease, heart failure, dysrhythmias, hypertension, diabetes
mellitus, lung disease, and renal insufficiency), medications
(beta blockers, angiotensin-converting enzyme (ACE) in-
hibitors, angiotensin II receptor antagonists, calcium channel
blockers, diuretics, nitrates, other antihypertensives, anti-
platelet medication, anticoagulants, statins, insulin therapy,
and systemic steroids). Lee’s revised cardiac risk index (RCRI)
was calculated using the aforementioned data. CPET param-
eters recorded for this studywere:VO2 at AT,VE/VCO2 at AT, and
the quality of the VO2/work rate (VO2/WR) and oxygen pulse
response. At York Hospital, a consultant anaesthetist trained
in CPET interprets the oxygen pulse graph as normal or
abnormal depending on the shape of the plotted line, corre-
sponding heart rate, and achievement of predicted values
calculated for weight, sex, age, and ethnicity. An abnormal
response is characterised by the onset of a plateau instead of a
continuing increasing response, or a decreasing inflection
accompanied by a corresponding compensatory increase in
heart rate. Similarly for VO2/WR, a consultant anaesthetist
interprets the graph of work rate and VO2 by time as normal or
abnormal depending on whether the plotted line of oxygen
consumption has a low trajectory compared with work rate,
includes a decreasing inflection point, or both.
Outcome data were gathered after hospital discharge from
the Trust’s core patient database. Status at discharge (alive or
dead), prolonged hospital length of stay (PHLOS), unplanned
critical care use, long-term status, and survival time were
recorded. PHLOS was defined as a length of stay greater than
that of the 75th centile of the whole study cohort. Unplanned
critical care use was defined as any unexpected admission or
re-admission to high dependency unit (HDU) or ICU from the
general surgical ward.
For increased risk of postoperative morbidity and mortal-
ity, AT was defined as a value of less than 11 ml1 kg1
min1,3,4 and VE/VCO2 risk (ventilatory inefficiency) was
defined as a value greater than 34 at the point of AT3,11 in
accordance with the clinical practice at the time. Oxygen pulse
response is a subjective assessment of the graph; oxygen pulse
by time (minutes). Peak VO2 could not be used in this study as
the CPET protocol used sub-maximal testing for a large ma-
jority of patients, resulting in 625 missing values.
Clinicians were informed of the CPET results, and patients
were stratified as either high or standard risk based on a
combination of CPET data (AT and VE/VCO2) and clinical risk
factors. Intraoperatively, patients received goal-directed fluid
therapy, and whether surgery was open or laparoscopically
assisted was recorded. After surgery, patients were allocated
to either HDU (level 2), or to a nursing enhanced unit (NEU,
level 1) on the general surgical wards. NEU is an area of eight
2 - Mann et al.
beds in a general surgical wardwith a nurse/patient ratio of 1:4
enabling closer observation andmonitoring than routine ward
care. Postoperative care was under the control of the surgical
team, or intensivists if the patient was on HDU or ICU.
The primary outcome was a composite of in-hospital
mortality and mortality within 30 days of surgery. Secondary
outcomes were 90-day and 2-yr mortality, prolonged hospital
stay, and unplanned critical care admission.
Bivariable analysis was used to test differences in patient
baseline demographics, risk factors, and outcomes. Analysis
included unpaired Student’s t-test for normally distributed
continuous variables or ManneWhitney U-test for non-
parametric data, and c2 or Fisher’s exact test for categorical
variables as appropriate. Differences between groups were
estimated using odds ratios (ORs) with 95% confidence in-
tervals (CIs) and Cox regression with backward selection to
control for confounders. KaplaneMeier curves were con-
structed to compare survival between oxygen pulse response
groups. SPSS Statistics was used for statistical analysis (SPSS
Statistics version 25; IBM Corporation, Armonk, NY, USA). A P-
value of less than 0.05 was considered statistically significant.
Results
A total of 1782 patients were assessed in the anaesthetic pre-
operative assessment clinic before colorectal surgery. Overall,
213 patients were excluded because oxygen pulse response
was unreported (described in Supplementary Table S1) and
355 were excluded as they did not have malignancy, leaving
1214 patients who underwent colorectal cancer surgery.
Twenty-six (2.1%) patients died within 30 days or during
their postoperative hospital stay. Age, sex (male), VE/VCO2 >34,
and oxygen pulse response were associated with all-cause
mortality using bivariable analysis (Table 1).
Oxygen pulse response
In the whole cohort, patients with a normal and abnormal
oxygen pulse response differed statistically in demographics,
co-morbidities, and CPET results (Supplementary Table S2). A
total of 246 (20.3%) patients exhibited an abnormal oxygen
pulse response, of whom 11 died, producing amortality rate of
4.5%. Themortality rate for patients with normal oxygen pulse
response was 1.5%.
In total, 1150 were eligible for multivariable Cox regression
analysis (see Supplementary Fig. S1). Table 2 displays the
adjusted ORs produced for the primary and secondary out-
comes. An abnormal oxygen pulse response remained inde-
pendently associated with 30-day, 90-day, and 2-yr mortality.
When controlled for patient sex, chronic obstructive pulmo-
nary disease (COPD), and VE/VCO2 >34, an abnormal oxygen
pulse had an increased risk for the primary outcome (OR¼2.75;
Table 1 Descriptive statistics of all cause mortality within 30 days. Categorical variables analysed by c2 or Fisher’s exact test (*),
continuous variables compared with independent t-test and displayed as mean (standard deviation, SD). Percentages calculated
including missing values. BMI, revised cardiac risk index (RCRI), VO2 at anaerobic threshold (AT), oxygen pulse response (O2PR), VO2/
work rate (VO2/WR).
All patients (n¼1214) 30-day mortality P-value
No (n¼1188) Yes (n¼26)
Age (yr), n¼1208 71.7 (8.8) 71.7 (8.8) 75.4 (9.0) 0.031
BMI (kg m2), n¼1179 27.3 (4.9) 27.3 (4.9) 26.8 (4.2) 0.56
Sex, n (%)
Male 713 (58.7) 692 (58.2) 21 (80.8) 0.021
Female 501 (41.3) 496 (41.8) 5 (19.2)
BMI category, n (%)
Underweight (<18.5) 15 (1.2) 14 (1.2) 1 (3.8) 0.33*
Healthy (18.5e24.9) 375 (30.9) 365 (30.7) 10 (38.4)
Overweight (25e29.9) 479 (39.5) 471 (39.6) 8 (30.8)
Obese (30) 310 (25.5) 303 (25.5) 7 (26.9)
Metastases, n (%) n¼1214
None 756 (62.3) 735 (61.9) 21 (80.8) 0.049
Metastases 458 (37.7) 453 (38.1) 5 (19.2)
Laparoscopic, n (%) n¼1214
Open 1014 (83.5) 991 (83.4) 23 (88.5) 0.79*
Laparoscopic 200 (16.5) 197 (16.6) 3 (11.5)
Lee’s RCRI, n (%) n¼1214
Low (<1%) 943 (77.7) 926 (77.9) 17 (65.4) 0.13
Elevated (>1%) 271 (22.3) 262 (22.1) 9 (34.6)
AT risk, n (%) n¼1205
11 ml kg1 min1 665 (54.8) 653 (53.5) 12 (46.2) 0.35
<11 ml kg1 min1 540 (44.5) 526 (44.3) 14 (53.8)
VE/VCO2 risk, n (%) n¼1193
34 729 (60) 721 (60.7) 8 (30.8) 0.003
>34 464 (38.2) 447 (37.6) 17 (65.4)
O2PR, n (%) n¼1214
Normal 969 (79.7) 953 (80.2) 15 (57.7) 0.005
Abnormal 246 (20.3) 235 (19.8) 11 (42.3)
VO2/WR response, n (%) n¼1213
Normal 1073 (88.4) 1053 (88.6) 20 (76.9) 0.11*
Abnormal 140 (1213) 134 (11.3) 6 (23.1)
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95% CI, 1.17e6.47; P¼0.02). Figures 1 and 2 display
KaplaneMeier plots for 30 day and 2 yr mortality, showing
short- and long-term survival for patients with normal and
abnormal oxygen pulse responses.
Ventilatory inefficiency
The characteristics of patients with and without ventilatory
efficiency (VE/VCO2 34 and >34) were significantly different in
most variables analysed, including demographics, co-
morbidities, and CPET results (Supplementary Table S3).
A total of 21 patients were excluded from bivariable anal-
ysis because of missing VE/VCO2 data. The primary outcome
occurred in 17 patients with VE/VCO2 >34 (3.7%) (OR¼3.43; 95%
CI, 1.47e8.01). Table 3 shows ventilatory inefficiency was also
associated with 90-day and 2-yr mortality, and prolonged LOS
using bivariable analysis (n¼1193). There was no evidence that
VE/VCO2was associated with unplanned critical care admission
(Table 3).
Ventilatory inefficiency and oxygen pulse response
combined
Comparing patients with a normal and abnormal oxygen pulse
response who had a VE/VCO2 34, showed no association with
the primary or secondary outcomes (Supplementary Table S4).
For patients with ventilatory inefficiency (VE/VCO2 >34), the
addition of having an abnormal pulse response increased the
risk of the primary outcome, 90 day and 2 yr mortality using
bivariable analysis. The rate of the primary outcome for this
group was 7.8%, compared with a rate of 1.9% of patients with
a VE/VCO2 >34 and a normal oxygen pulse response (OR¼4.47;
95% CI, 1.62e12.34) (Table 4). There was no evidence that an
abnormal oxygen pulse response was associated with
increased length of hospital stay or unplanned critical care
admission in patients with an increased VE/VCO2.
Discussion
We have demonstrated that an abnormal oxygen pulse
response is independently associated with mortality after
colorectal surgery, both in the short- and long-term. The risk is
especially increased for those patients exhibiting ventilatory
inefficiency and an abnormal oxygen pulse. The results do not
infer causation, and confounders are difficult to identify and
control; however, to our knowledge, this is the largest cohort
of patients inwhich the association between abnormal oxygen
pulse response and mortality was studied.
There are few studies exploring the use of oxygen pulse
response in predicting postoperative outcomes. A small
retrospective study assessed postoperative complications and
found oxygen pulse to be a significant predictor; however, it is
not clear how oxygen pulse abnormality was defined.14 A
retrospective study modelled preoperative variables to predict
5-yr survival, and oxygen pulse at AT was a significant pre-
dictor of mortality. However, this study’s population was
heterogeneous for surgical type, which included awide variety
of mortality rates, and did not include co-morbidities as pre-
dictive variables meaning their effects as confounders are
unknown.15
Fig 1. KaplaneMeier plot for 30 day mortality comparing normal
and abnormal oxygen pulse response.
Table 2 Coefficients for oxygen pulse response calculated by
multivariable Cox regression when analysing primary and
secondary outcomes. 30 day mortality controlled for sex,
chronic obstructive pulmonary disease (COPD), and VE/VCO2
34; 90 day mortality controlled for age, sex, and COPD; 2 yr
mortality controlled for age, sex, metastases, BMI (contin-
uous), COPD, and VE/VCO2 34. All eligible cases included in
analysis, caseswithmissing data were excluded (n¼1150). Full
regression model included in supplementary material. CI,
confidence interval.
Outcome Oxygen pulse response
Cox regression coefficient
B P-value Exp(B) 95% CI Exp(B)
30-day mortality 1.01 0.02 2.75 1.17e6.47
90-day mortality 1.02 0.005 2.76 1.36e5.60
2-yr mortality 0.45 0.014 1.56 1.10e2.23
Fig 2. KaplaneMeier plot for 2-yr mortality comparing normal
and abnormal oxygen pulse response.
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In non-surgical populations, peak oxygen pulse and oxygen
pulse response have been associated with increased mortality
in healthy individuals and those with heart failure.16,17 In a
study investigating patients presenting with exertional dysp-
noea, 26.5% of patients had an abnormal oxygen pulse
response, correlating with myocardial dysfunction as
demonstrated by echocardiography.18 There is conflicting ev-
idence for ischaemic heart disease; oxygen pulse response has
been shown to be superior at identifying EIMD than standard
testing such as exercise ECG,12 but in a recent study did not
correlate with coronary artery disease with >50% stenosis.19
Other studies have shown severity of ischaemic heart dis-
ease and left ventricular function to correlate with abnormal
oxygen pulse response.20,21 Guidelines also state the use of
oxygen pulse in the reporting standards of CPET, but it has
been excluded from preoperative risk assessment recom-
mendations.7 The uncertainty around oxygen pulse with
ischaemic heart diseasemay stem from the varying severity of
disease and the emergence of non-obstructive coronary
microvascular endothelial dysfunction as a recognised risk
factor for cardiovascular events.22,23
Exercise-induced myocardial dysfunction
Using oxygen pulse response adds incremental value for pre-
dicting short- and long-term survival. In multivariable Cox
regression, an abnormal oxygen pulse response was associ-
ated with nearly three times the risk of 30-day and 90-day
mortality. The subgroup analyses offer possible insight to
where EIMD may be most significant; if a patient has normal
functional capacity (VE/VCO2 34), then the presence of EIMD
had no effect on 30-daymortality. It appears that patients with
normal functional capacity are capable of meeting the physi-
ological demands of colorectal surgery regardless of any
possible underlying cardiorespiratory disease. However, if
patients have reduced functional capacity (VE/VCO2 >34), then
the presence of EIMD significantly increases mortality with
approximately four and a half times the odds of 30-day mor-
tality. Although plausible, and strengthened by the association
seen in the multivariable analysis, it is important to note that
these patient cohorts differed significantly in baseline
demographics and patient characteristics and caution is
advised when interpreting these unadjusted subgroup
analyses.
The current American Heart Association (AHA) guidelines
for perioperative cardiovascular management of noncardiac
surgery24 use the RCRI to direct patients to low risk (<1%) or
elevated risk pathways. The elevated risk group have a func-
tional capacity assessment and if this is reduced, they proceed
to further investigation. In this study, 943 out of 1214 patients
(77.7%) would be deemed low risk using the AHA guidelines
andwould proceed to surgery. However, using VE/VCO2 >34 as a
surrogate for reduced functional capacity, 342 out of 943
(36.3%) patients, defined as higher risk by CPET, would have
undergone surgery without further investigation. Further-
more, out of these 342 patients, 102 (29.8%) had an abnormal
oxygen pulse response which this study has shown to be
significantly associated with mortality (Supplementary
Fig. S2).
CPET may be revealing previously undiagnosed functional
limitation from subclinical pathology, which is being missed
by medical history, scoring systems, or static testing. It ap-
pears that in order to identify a greater proportion of those at
high risk, all patients undergoing major surgery require such
an assessment. These findings are in keeping with current
literature, which has shown a raised VE/VCO2 to be prognostic
in surgical patients3,25e27 and also echoes what was originally
shown by Older and colleagues,4 where a significant propor-
tion of patients without known ischaemia had a reduced AT
and increasedmortality. Furthermore, the same study showed
that patients with known ischaemic heart disease and a
decreased AT had a significantly increased risk of mortality,4
which highlights the need for CPET in high-risk patients.
Limitations
This is a retrospective analysis, with the limitations of this
type of research. A subjective assessment of oxygen pulse was
used despite the inherent nature of inter-observer variation
Table 3 Bivariable analysis comparing VE/VCO2 34 and >34 for
primary and secondary outcomes. OR, odds ratio; CI, confi-





OR 95% CI P-value
30-day mortality
No 721 (98.9) 447 (96.3) 3.43 1.47e8.01 0.003
Yes 8 (1.1) 17 (3.7)
90-day mortality
No 715 (98.1) 444 (95.7) 2.30 1.15e4.60 0.016
Yes 14 (1.9) 20 (4.3)
2-yr mortality
No 657 (90.1) 368 (79.3) 2.38 1.71e3.32 <0.001
Yes 72 (9.9) 96 (20.7)
PHLOS
No 576 (79.0) 322 (69.4) 1.66 1.27e2.17 <0.001
Yes 153 (21.0) 142 (30.6)
Unplanned critical care
No 680 (93.3) 427 (92.0) 1.20 0.77e1.87 0.415
Yes 49 (6.7) 37 (8.0)
Table 4 Bivariable analysis of patients with a reduced func-
tional capacity (VE/VCO2>34), comparing normal and abnormal
oxygen pulse responses. Odds ratio (OR), confidence intervals
(CI), and prolonged hospital length of stay (PHLOS).






No 317 (98.1) 130 (92.2) 4.47 1.62e12.34 0.002
Yes 6 (1.9) 11 (7.8)
90-day mortality
No 315 (97.5) 129 (91.5) 3.66 1.46e9.17 0.003
Yes 8 (2.5) 12 (8.5)
2-yr mortality
No 265 (82.0) 103 (73.0) 1.69 1.06e2.69 0.028
Yes 58 (18.0) 38 (27.0)
PHLOS
No 224 (69.3) 98 (69.5) 0.99 0.64e1.53 0.974
Yes 99 (30.7) 43 (30.5)
Unplanned critical care
No 301 (93.2) 126 (89.4) 1.63 0.82e3.24 0.162
Yes 22 (6.8) 15 (10.6)
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and stems from no documented consensus on its interpreta-
tion. The low incidence of the primary outcome and finding
EIMD in patients without known cardiac disease is reflected in
the wide 95% CIs and inability to show difference between
some groups. During the collection of the data and patient
management, clinicians were not blinded to the CPET results,
incorporating an unknown bias to the study. This perhaps
reduced the magnitude of association seen in this study, as
these patients were identified as higher risk and treated as
such, although this was usually defined by the presence of
impaired functional capacity, rather than EIMD. The results
are derived from a large and unfiltered group of patients in one
surgical specialty, treated without the constraints of a study
protocol, but conversely this may make the data more repre-
sentative of real day-to-day practice.
Owing to the use of sub-maximal testing, VO2 peak was not
available for analysis because of a large proportion of missing
data and hinders the study’s comparability. There were also a
large number of patients excluded from the analysis because
of amissing oxygen pulse response, which are described in the
Supplementary material. Importantly, there was no difference
in mortality between the included and missing patients, and
there was no obvious pattern to the statistically different
variables, which would infer a reason for the missing oxygen
pulse response.
The study lacks comparison of oxygen pulse response with
other investigations of heart disease. Comparing ECG changes
during CPET with oxygen pulse response was unrelia-
bledfirstly, because gas exchange evidence of EIMD occurs
several minutes before ST segment changes are seen,12 and
secondly, with a submaximal testing protocol, inmany cases it
is likely the test would be completed before the onset of ST
changes.12
The primary outcome of 30-day mortality diverts from
recent practice to use 90-day mortality as an improved mea-
sure of survival and was a result of an earlier study protocol
design. However, the secondary outcomes included 90-day
mortality, which also demonstrated the same associations
with a similar magnitude.
Conclusions
The results from this study provide evidence that EIMD
defined by an abnormal oxygen pulse response, is indepen-
dently associated with mortality after colorectal cancer sur-
gery. Patients with a reduced functional capacity as defined by
a VE/VCO2 >34, appear to be of particular risk of mortality in the
presence of EIMD. It appears advantageous to objectively
assess functional capacity at the first instance of a risk strat-
ification algorithm, preferably with CPET and including the
measurement oxygen pulse response. Further research is
warranted to define more precisely a normal and an abnormal
oxygen pulse response, and to further examine the relation-
ship with morbidity and mortality after major surgery.
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